US FDA limits use of J & J corona vaccine at risk of thrombosis | Reuters

The US Food and Drug Administration (FDA) announced on May 5 that it will limit the use of Johnson & Johnson’s (J & J) new coronavirus vaccine because it is at risk of causing abnormal thrombosis. Taken in New York in March 2021 (2022 Reuters / Shannon Stapleton) [Reuters]–The US Food and Drug Administration (FDA) […]

First human infection in China, H3N8 bird flu | Reuters

On April 26, the National Health Commission of China announced that the transmission of H3N8 avian influenza to humans was confirmed for the first time. The photo was taken in Hong Kong in April 2013 (2022 Reuters / Bobby Yip) [Beijing, 26th Reuters]–The China National Health and Health Commission announced on the 26th that the […]

Column: Risks of both rising inflation and economic slowdown, what are the investment tactics in an emergency = Mr. Norihiro Fujito | Reuters

Norihiro Fujito Mitsubishi UFJ Morgan Stanley Securities [Tokyo 9th]–The Russian invasion of Ukraine suddenly reversed the hands of the clock 60-70 years ago. The 1956 “Hungarian Revolution” and the 1968 “Prague Spring” in Czechoslovakia are a return to the time when they were overrun by Soviet tanks. On March 9, the Russian invasion of Ukraine […]

Column: Normalization of US monetary policy, the awaiting challenge of “separation from the market” = Mr. Tetsuya Inoue | Reuters

Tetsuya Inoue Senior Researcher, Financial Digital Business Research Department, Nomura Research Institute [Tokyo 29th]–The Federal Reserve Board (FRB) met at the US Federal Open Market Committee (FOMC) in July, which is a condition for slowing asset purchases (tapering). We confirmed that the US economy is making steady progress in response to “advancement.” At the Federal […]

Angle: Experts question the FDA for Alzheimer’s drug approval | Reuters

[Reuters]— Alzheimer’s disease treatment “Aducanumab”, which was jointly developed by US pharmaceutical giant Biogen with Eisai, was approved by the US Food and Drug Administration (FDA) for the first time in about 20 years. It became a new drug for. On June 11, the U.S. drug giant Biogen co-developed with Eisai the Alzheimer’s disease treatment […]